193 related articles for article (PubMed ID: 20373910)
21. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.
Longest W; Spence B; Hindle M
J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):317-339. PubMed ID: 31287369
[TBL] [Abstract][Full Text] [Related]
22. Optimization and Dose Estimation of Aerosol Delivery to Non-Human Primates.
MacLoughlin RJ; van Amerongen G; Fink JB; Janssens HM; Duprex WP; de Swart RL
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):281-7. PubMed ID: 26646908
[TBL] [Abstract][Full Text] [Related]
23. Aerosol delivery during spontaneous breathing with different types of nebulizers- in vitro/ex vivo models evaluation.
Lin HL; Fang TP; Cho HS; Wan GH; Hsieh MJ; Fink JB
Pulm Pharmacol Ther; 2018 Feb; 48():225-231. PubMed ID: 29277689
[TBL] [Abstract][Full Text] [Related]
24. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Evaluation of Aerosols Delivered via the Nasal Route.
El Taoum KK; Xi J; Kim J; Berlinski A
Respir Care; 2015 Jul; 60(7):1015-25. PubMed ID: 25587167
[TBL] [Abstract][Full Text] [Related]
26. Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.
Golshahi L; Longest PW; Azimi M; Syed A; Hindle M
Respir Care; 2014 Oct; 59(10):1476-86. PubMed ID: 24917454
[TBL] [Abstract][Full Text] [Related]
27. Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) system.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23 Suppl 1(Suppl 1):iii-v. PubMed ID: 20373913
[No Abstract] [Full Text] [Related]
28. Comparison of Vibrating Mesh, Jet, and Breath-Enhanced Nebulizers During Mechanical Ventilation.
Ashraf S; McPeck M; Cuccia AD; Smaldone GC
Respir Care; 2020 Oct; 65(10):1419-1426. PubMed ID: 32694180
[TBL] [Abstract][Full Text] [Related]
29. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency.
Brand P; Schulte M; Wencker M; Herpich CH; Klein G; Hanna K; Meyer T
Eur Respir J; 2009 Aug; 34(2):354-60. PubMed ID: 19251783
[TBL] [Abstract][Full Text] [Related]
30. From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.
Bianco F; Ricci F; Catozzi C; Murgia X; Schlun M; Bucholski A; Hetzer U; Bonelli S; Lombardini M; Pasini E; Nutini M; Pertile M; Minocchieri S; Simonato M; Rosa B; Pieraccini G; Moneti G; Lorenzini L; Catinella S; Villetti G; Civelli M; Pioselli B; Cogo P; Carnielli V; Dani C; Salomone F
Respir Res; 2019 Jul; 20(1):134. PubMed ID: 31266508
[TBL] [Abstract][Full Text] [Related]
31. Capturing the efficiency of vibrating mesh nebulizers: minimizing upper airway deposition.
Sagalla RB; Smaldone GC
J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):341-8. PubMed ID: 25105472
[TBL] [Abstract][Full Text] [Related]
32. Nebulized albuterol delivery in a model of spontaneously breathing children with tracheostomy.
Berlinski A
Respir Care; 2013 Dec; 58(12):2076-86. PubMed ID: 23674810
[TBL] [Abstract][Full Text] [Related]
33. Quantifying Aerosol Delivery in Simulated Spontaneously Breathing Patients With Tracheostomy Using Different Humidification Systems With or Without Exhaled Humidity.
Ari A; Harwood R; Sheard M; Alquaimi MM; Alhamad B; Fink JB
Respir Care; 2016 May; 61(5):600-6. PubMed ID: 26908921
[TBL] [Abstract][Full Text] [Related]
34. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With a Single-Limb Circuit.
Berlinski A; Velasco J
Respir Care; 2019 Nov; 64(11):1366-1370. PubMed ID: 31113855
[TBL] [Abstract][Full Text] [Related]
35. Same lung deposited dose in dog dosing a fine and coarse aerosol indicates no difference in intranasal filtration.
Brülls M; Oag S; Karlsson CA; Lamm Bergström E
Int J Pharm; 2022 Aug; 624():121977. PubMed ID: 35792234
[TBL] [Abstract][Full Text] [Related]
36. Effect of nebulizer configuration on delivery of aerosolized tobramycin.
O'Riordan TG; Amram JC
J Aerosol Med; 1997; 10(1):13-23. PubMed ID: 10166359
[TBL] [Abstract][Full Text] [Related]
37. Effects of flow pattern, device and formulation on particle size distribution of nebulized aerosol.
Hu J; Zhang R; Beng H; Deng L; Ke Q; Tan W
Int J Pharm; 2019 Apr; 560():35-46. PubMed ID: 30664994
[TBL] [Abstract][Full Text] [Related]
38. Influence of realistic airflow rate on aerosol generation by nebulizers.
Vecellio L; Kippax P; Rouquette S; Diot P
Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
[TBL] [Abstract][Full Text] [Related]
39. SPECT-CT Comparison of Lung Deposition using a System combining a Vibrating-mesh Nebulizer with a Valved Holding Chamber and a Conventional Jet Nebulizer: a Randomized Cross-over Study.
Dugernier J; Hesse M; Vanbever R; Depoortere V; Roeseler J; Michotte JB; Laterre PF; Jamar F; Reychler G
Pharm Res; 2017 Feb; 34(2):290-300. PubMed ID: 27822851
[TBL] [Abstract][Full Text] [Related]
40. Vibrating membrane devices deliver aerosols more efficient than standard devices: a study in a neonatal upper airway model.
Tiemersma S; Minocchieri S; van Lingen RA; Nelle M; Devadason SG
J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):280-6. PubMed ID: 23273244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
